T. Rowe Price Associates’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7M | Buy |
2,383,953
+563,538
| +31% | +$5.37M | ﹤0.01% | 937 |
|
|
2025
Q1 | $19M | Sell |
1,820,415
-582,037
| -24% | -$6.09M | ﹤0.01% | 969 |
|
|
2024
Q4 | $56.6M | Sell |
2,402,452
-233,841
| -9% | -$5.51M | 0.01% | 718 |
|
|
2024
Q3 | $94.7M | Buy |
2,636,293
+270,224
| +11% | +$9.71M | 0.01% | 581 |
|
|
2024
Q2 | $83.5M | Buy |
2,366,069
+1,233,977
| +109% | +$43.5M | 0.01% | 581 |
|
|
2024
Q1 | $32.1M | Buy |
1,132,092
+1,118,590
| +8,285% | +$31.8M | ﹤0.01% | 843 |
|
|
2023
Q4 | $180K | Sell |
13,502
-161,885
| -92% | -$2.16M | ﹤0.01% | 2576 |
|
|
2023
Q3 | $1.57M | Buy |
175,387
+164,444
| +1,503% | +$1.47M | ﹤0.01% | 1567 |
|
|
2023
Q2 | $124K | Sell |
10,943
-280,367
| -96% | -$3.18M | ﹤0.01% | 2647 |
|
|
2023
Q1 | $3.36M | Buy |
291,310
+252,232
| +645% | +$2.91M | ﹤0.01% | 1289 |
|
|
2022
Q4 | $453K | Buy |
39,078
+370
| +1% | +$4.29K | ﹤0.01% | 2173 |
|
|
2022
Q3 | $493K | Buy |
38,708
+2,148
| +6% | +$27.4K | ﹤0.01% | 2131 |
|
|
2022
Q2 | $251K | Buy |
36,560
+102
| +0.3% | +$700 | ﹤0.01% | 2508 |
|
|
2022
Q1 | $351K | Buy |
36,458
+700
| +2% | +$6.74K | ﹤0.01% | 2477 |
|
|
2021
Q4 | $425K | Sell |
35,758
-600
| -2% | -$7.13K | ﹤0.01% | 2461 |
|
|
2021
Q3 | $590K | Buy |
+36,358
| New | +$590K | ﹤0.01% | 2295 |
|
|
2021
Q1 | – | Sell |
-484,952
| Closed | -$10.2M | – | 2847 |
|
|
2020
Q4 | $10.2M | Sell |
484,952
-6,519
| -1% | -$137K | ﹤0.01% | 1346 |
|
|
2020
Q3 | $9.92M | Buy |
+491,471
| New | +$9.92M | ﹤0.01% | 1302 |
|